Who owns BIO-TECHNE Corp (TECH)? Elite investor 13F holders

10 tracked elite investors reported holding BIO-TECHNE Corp as of 2026-09-30, including Ruane Cunniff LP, Mairs & Power Funds, D.E. Shaw, Maverick Capital, Weitz Investment Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

10 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Ruane Cunniff LPBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:00242255397.00 USD3342837.000000SharesreduceOriginal filing
Mairs & Power FundsBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:0092301038.00 USD1273645.000000SharesreduceOriginal filing
D.E. ShawBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:00183468531.00 USD2531648.000000SharesaddOriginal filing
Maverick CapitalBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:00111285657.00 USD1535610.000000SharesholdOriginal filing
Weitz Investment ManagementBIO-TECHNE CORPSHARE2026-09-302026-11-12 00:00:0018284181.00 USD252300.000000SharesreduceOriginal filing
Durable Capital PartnersBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:0036377259.00 USD501963.000000SharesholdOriginal filing
Ananym CapitalBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000SharesexitedOriginal filing
Gotham Asset ManagementBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:005302485.00 USD73168.000000SharesaddOriginal filing
GAMCOBIO-TECHNE CORPSHARE2026-09-302026-11-12 00:00:002670520.00 USD36850.000000SharesaddOriginal filing
Bridgewater AssociatesBIO-TECHNE CORPSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000SharesexitedOriginal filing
Renaissance Technologies LLCBIO-TECHNE CORPSHARE2026-09-302026-11-12 00:00:00934863.00 USD12900.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsBIO-TECHNE CORPSHARE2026-09-302026-11-17 00:00:003334.00 USD46.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown